Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The price of Cellectar Biosciences Inc (NASDAQ: CLRB) closed at $0.34 in the last session, down -2.29% from day before closing price of $0.35. In other words, the price has decreased by -$2.29 from its previous closing price. On the day, 0.57 million shares were traded. CLRB stock price reached its highest trading level at $0.3571 during the session, while it also had its lowest trading level at $0.336.
Ratios:
We take a closer look at CLRB’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.77 and its Current Ratio is at 1.77. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLRB now has a Market Capitalization of 14110144 and an Enterprise Value of 59341328.
Stock Price History:
Over the past 52 weeks, CLRB has reached a high of $4.45, while it has fallen to a 52-week low of $0.22. The 50-Day Moving Average of the stock is -72.48%, while the 200-Day Moving Average is calculated to be -85.19%.
Shares Statistics:
According to the various share statistics, CLRB traded on average about 1.86M shares per day over the past 3-months and 2456410 shares per day over the past 10 days. A total of 40.57M shares are outstanding, with a floating share count of 40.04M. Insiders hold about 2.97% of the company’s shares, while institutions hold 34.01% stake in the company. Shares short for CLRB as of 1730332800 were 1835227 with a Short Ratio of 1.51, compared to 1727654400 on 2203374. Therefore, it implies a Short% of Shares Outstanding of 1835227 and a Short% of Float of 5.06.
